Fundamental Analysis of CHECKPOINT THERAPEUTICS INC(NASDAQ:CKPT) stock

Fundamental Rating

Overall CKPT gets a fundamental rating of 1 out of 10. We evaluated CKPT against 568 industry peers in the Biotechnology industry. Both the profitability and financial health of CKPT have multiple concerns. CKPT is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year CKPT has reported negative net income.

In the past year CKPT has reported a negative cash flow from operations.

CKPT had negative earnings in each of the past 5 years.

CKPT had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

CKPT's Return On Assets of -897.24% is on the low side compared to the rest of the industry. CKPT is outperformed by 98.94% of its industry peers.

		Industry Rank	Sector Rank
ROA	-897.24%
ROE	N/A
ROIC	N/A

ROA(3y)-512.31%

ROA(5y)-336.54%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

CKPT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for CKPT has been increased compared to 1 year ago.

The number of shares outstanding for CKPT has been increased compared to 5 years ago.

There is no outstanding debt for CKPT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of -113.05, we must say that CKPT is in the distress zone and has some risk of bankruptcy.

CKPT has a worse Altman-Z score (-113.05) than 97.70% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-113.05

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

CKPT has a Current Ratio of 0.29. This is a bad value and indicates that CKPT is not financially healthy enough and could expect problems in meeting its short term obligations.

CKPT has a worse Current ratio (0.29) than 95.40% of its industry peers.

CKPT has a Quick Ratio of 0.29. This is a bad value and indicates that CKPT is not financially healthy enough and could expect problems in meeting its short term obligations.

With a Quick ratio value of 0.29, CKPT is not doing good in the industry: 94.69% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	0.29
Quick Ratio	0.29

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CKPT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 59.29%, which is quite impressive.

CKPT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -72.35%.

The Revenue for CKPT have been decreasing by -50.63% on average. This is quite bad

EPS 1Y (TTM)59.29%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%20.69%

Revenue 1Y (TTM)-72.35%

Revenue growth 3Y-54.17%

Revenue growth 5Y-50.63%

Sales Q2Q%-100%

3.2 Future

The Earnings Per Share is expected to grow by 39.40% on average over the next years. This is a very strong growth

The Revenue is expected to grow by 1950.54% on average over the next years. This is a very strong growth

EPS Next Y76.01%

EPS Next 2Y39.4%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-72.2%

Revenue Next 2Y1950.54%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

CKPT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CKPT. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as CKPT's earnings are expected to grow with 39.40% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y39.4%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for CKPT!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CHECKPOINT THERAPEUTICS INC

NASDAQ:CKPT (12/18/2024, 4:46:06 PM)

After market: 3.61 +0.04 (+1.12%)

3.57

-0.15 (-3.9%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap174.32M

Analysts

Price Target

Short Float %

Short Ratio

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-897.24%
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.01

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	0.29
Quick Ratio	0.29
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)59.29%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y76.01%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-72.35%

Revenue growth 3Y-54.17%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

CHECKPOINT THERAPEUTICS INC (CKPT)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens